A method for preparing polybutene by polymerization of a raw material of a carbon number 4 (C4) compounds having an isobutene amount of 50 to 75% by weight, is disclosed. The raw material of C4 compounds is selected from the group consisting of (a) C4 compound material obtained by adding high purity isobutene to C4 raffinate-1; (b) C4 compound material obtained by adding high amount isobutene mixture which is generated in an olefin conversion unit (OCU) process to C4 raffinate-1; (c) C4 compound material obtained by adding high purity to butane-butene oil (B-B oil); (d) C4 compound material obtained by adding high amount isobutene mixture which is generated in an olefin conversion unit (OCU) process to butane-butene oil (B-B oil); (e) C4 compound material obtained by adding a dilute solvent to high purity isobutene; (f) C4 compound material obtained by adding a dilute solvent to high amount isobutene mixture which is generated in an olefin conversion unit (OCU) process; (g) C4 compound material obtained by adding high purity isobutene to a mixture generated in dehydrogenation reaction that converts isobutane to isobutene; and (h) C4 compound material obtained by adding high amount isobutene mixture which is generated in an olefin conversion unit (OCU) process to a mixture generated in dehydrogenation reaction that converts isobutane to isobutene.

A method for preparing polybutene by polymerization of a raw material of a carbon number 4 (C4) compounds having an isobutene amount of 50 to 75% by weight, is disclosed. The raw material of C4 compounds is selected from the group consisting of (a) C4 compound material obtained by adding high purity isobutene to C4 raffinate-1; (b) C4 compound material obtained by adding high amount isobutene mixture which is generated in an olefin conversion unit (OCU) process to C4 raffinate-1; (c) C4 compound material obtained by adding high purity to butane-butene oil (B-B oil); (d) C4 compound material obtained by adding high amount isobutene mixture which is generated in an olefin conversion unit (OCU) process to butane-butene oil (B-B oil); (e) C4 compound material obtained by adding a dilute solvent to high purity isobutene; (f) C4 compound material obtained by adding a dilute solvent to high amount isobutene mixture which is generated in an olefin conversion unit (OCU) process; (g) C4 compound material obtained by adding high purity isobutene to a mixture generated in dehydrogenation reaction that converts isobutane to isobutene; and (h) C4 compound material obtained by adding high amount isobutene mixture which is generated in an olefin conversion unit (OCU) process to a mixture generated in dehydrogenation reaction that converts isobutane to isobutene.

The invention relates to a method for manufacturing a paper substrate suitable for binding silicone in a catalytic hydrosilation reaction and products thereof, wherein the molecular weight of polyvinyl alcohol is used to control the viscosity of the water-based acetalization reaction, such that a paper substrate may be coated with acetalized polyvinyl alcohol that contains high amount of functional vinyl groups, wherein the functional vinyl groups are part of catenated carbon structures which contain at least 4 carbon atoms and which have an acetal connectivity with the backbone chain of the acetalized polyvinyl alcohol.

The invention relates to a method for manufacturing a paper substrate suitable for binding silicone in a catalytic hydrosilation reaction and products thereof, wherein the molecular weight of polyvinyl alcohol is used to control the viscosity of the water-based acetalization reaction, such that a paper substrate may be coated with acetalized polyvinyl alcohol that contains high amount of functional vinyl groups, wherein the functional vinyl groups are part of catenated carbon structures which contain at least 4 carbon atoms and which have an acetal connectivity with the backbone chain of the acetalized polyvinyl alcohol.

A method for manufacturing a heat resistant resin composition having superior dispersibility of maleimide-based copolymer, the method including: a melt-kneading step to melt and knead a maleimide-based copolymer (A) and at least one resin (B) selected from the group consisting of ABS resin, ASA resin, AES resin, and SAN resin with an extruder; wherein: a ratio of a melt viscosity of the maleimide-based copolymer (A) with respect to a melt viscosity of the resin (B) obtained with a shear rate of 120/sec and a cylinder temperature of a kneading unit of the extruder is 1.0 or higher and lower than 3.4, is provided.

This invention relates to radiopaque polymers and to their use, particularly in the manufacture of medical devices and in methods of medical treatment, including therapeutic embolization. In particular embodiments the present disclosure relates to a hydrophilic polymer comprising pendent groups which a phenyl ring is substituted with one or more iodine groups and one or more non-iodine groups as described in more detail herein.

This invention relates to radiopaque polymers and to their use, particularly in the manufacture of medical devices and in methods of medical treatment, including therapeutic embolization. In particular embodiments the present disclosure relates to a hydrophilic polymer comprising pendent groups which a phenyl ring is substituted with one or more iodine groups and one or more non-iodine groups as described in more detail herein.

The present disclosure relates to radiopaque PVA polymers where the PVA has a first pendant group and a second pendant group, wherein the first pendant group comprises a first phenyl group bearing 1 to 5 iodine atoms, and the second pendant group comprises either (a) a second phenyl group bearing 1 to 3 substituents selected from the group W and optionally 1 to 4 iodine substituents, the group(s) W and the optional iodines being the sole substituents of the second phenyl group. Each W is selected from —OH, —COOH, —SO.sub.3H, —OPO.sub.3H.sub.2, —O—(C.sub.1-4alkyl), —O—(C.sub.1-4alkyl)OH, —O—(C.sub.1-4alkyl)R.sup.2, —O—(C.sub.2H.sub.5O).sub.qR.sup.1—(C═O)—O—C.sub.1-4alkyl and —O—(C═O)C.sub.1-4alkyl; wherein R.sup.1 is H or C.sub.1-4 alkyl; R.sup.2 is —COOH, —SO.sub.3H, or —OPO.sub.3H.sub.2; q is an integer from 1 to 4; wherein the group W may be in the form of a pharmaceutically acceptable salt; or (b) a pyridyl group; which is optionally in the form of a pyridinium ion.

The present disclosure relates to radiopaque PVA polymers where the PVA has a first pendant group and a second pendant group, wherein the first pendant group comprises a first phenyl group bearing 1 to 5 iodine atoms, and the second pendant group comprises either (a) a second phenyl group bearing 1 to 3 substituents selected from the group W and optionally 1 to 4 iodine substituents, the group(s) W and the optional iodines being the sole substituents of the second phenyl group. Each W is selected from —OH, —COOH, —SO.sub.3H, —OPO.sub.3H.sub.2, —O—(C.sub.1-4alkyl), —O—(C.sub.1-4alkyl)OH, —O—(C.sub.1-4alkyl)R.sup.2, —O—(C.sub.2H.sub.5O).sub.qR.sup.1—(C═O)—O—C.sub.1-4alkyl and —O—(C═O)C.sub.1-4alkyl; wherein R.sup.1 is H or C.sub.1-4 alkyl; R.sup.2 is —COOH, —SO.sub.3H, or —OPO.sub.3H.sub.2; q is an integer from 1 to 4; wherein the group W may be in the form of a pharmaceutically acceptable salt; or (b) a pyridyl group; which is optionally in the form of a pyridinium ion.

The present disclosure relates to radiopaque PVA polymers where the PVA has a first pendant group and a second pendant group, wherein the first pendant group comprises a first phenyl group bearing 1 to 5 iodine atoms, and the second pendant group comprises either (a) a second phenyl group bearing 1 to 3 substituents selected from the group W and optionally 1 to 4 iodine substituents, the group(s) W and the optional iodines being the sole substituents of the second phenyl group. Each W is selected from —OH, —COOH, —SO.sub.3H, —OPO.sub.3H.sub.2, —O—(C.sub.1-4alkyl), —O—(C.sub.1-4alkyl)OH, —O—(C.sub.1-4alkyl)R.sup.2, —O—(C.sub.2H.sub.5O).sub.qR.sup.1 —(C═O)—O— C.sub.1-4alkyl and —O—(C═O)C.sub.1-4alkyl; wherein R.sup.1 is H or C.sub.1-4 alkyl; R.sup.2 is —COOH, —SO.sub.3H, or —OPO.sub.3H.sub.2; q is an integer from 1 to 4; wherein the group W may be in the form of a pharmaceutically acceptable salt; or (b) a pyridyl group; which is optionally in the form of a pyridinium ion.